Cargando…

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder

BACKGROUND: Opioid use disorder (OUD) is a growing crisis among pregnant and postpartum people. Psychiatric comorbidities are common, yet how they impact OUD treatment outcomes is not well characterized. The aim of this study was to assess the association of psychiatric comorbidities and receipt of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shadowen, Hannah, Violante, Stephanie, Gataric, Andrea, Goulding, Alison N., Martin, Caitlin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835555/ https://www.ncbi.nlm.nih.gov/pubmed/36644222 http://dx.doi.org/10.1016/j.dadr.2022.100121

Ejemplares similares

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Listening to women and pregnant and postpartum people: Qualitative research to inform opioid use disorder treatment for pregnant and postpartum people
por: Guille, Constance, et al.
Publicado: (2022)

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
por: Wang, Xi, et al.
Publicado: (2023)

A qualitative exploration of the eight dimensions of wellness in opioid use disorder recovery during the postpartum period
por: Mallahan, Stephanie, et al.
Publicado: (2023)

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021
por: del Pozo, Brandon, et al.
Publicado: (2023)

Opportunities to expand postpartum support for those in recovery from opioid use disorder: Results from a qualitative study
por: Allen, Alicia, et al.
Publicado: (2023)

Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice
por: Hamood, Yesmine, et al.
Publicado: (2022)

Incarceration status at buprenorphine initiation and OUD treatment outcomes during pregnancy
por: Nguyen, Andrea, et al.
Publicado: (2023)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
por: John, William S., et al.
Publicado: (2022)

Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023)

An observational study on the use of long acting buprenorphine (Sublocade) and a Tamper resistant PICC for Outpatient IV antibiotic administration in Patients with serious infections and Opioid Use Disorder; The STOP OUD project
por: Pineo, Thomas, et al.
Publicado: (2021)

Internet-based CBT for patients with depressive disorders in primary and psychiatric care: Is it effective and does comorbidity affect outcome?
por: Flygare, Anna-Lena, et al.
Publicado: (2019)

The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022)

Medicaid expansion in Oregon and postpartum healthcare among people with and without prenatal substance use disorder()
por: Haight, Sarah C., et al.
Publicado: (2022)

What Recovery Means to Postpartum Women in Treatment for Opioid Use Disorder
por: Shadowen, Caroline, et al.
Publicado: (2022)

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
por: Winstanley, Erin L., et al.
Publicado: (2022)

Gambling disorders, gambling type preferences, and psychiatric comorbidity among the Thai general population: Results of the 2013 National Mental Health Survey
por: Assanangkornchai, Sawitri, et al.
Publicado: (2016)

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements
por: Silwal, Anita, et al.
Publicado: (2023)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
por: McFadden, Lisa M.
Publicado: (2023)

Similar COVID-19 incidence to the general population in people with opioid use disorder receiving integrated outpatient clinical care
por: Vallecillo, Gabriel, et al.
Publicado: (2022)

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
por: Parlier-Ahmad, Anna Beth, et al.
Publicado: (2021)

Patient reported preferences for sleep interventions among women receiving buprenorphine for opioid use disorder
por: Eglovitch, Michelle, et al.
Publicado: (2023)

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
por: Roy, Payel Jhoom, et al.
Publicado: (2023)

Associations among the opioid receptor gene (OPRM1) A118G polymorphism, psychiatric symptoms, and quantitative EEG in Korean males with gambling disorder: A pilot study
por: Kim, Kyoung Min, et al.
Publicado: (2019)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program
por: Ward, Kathleen M., et al.
Publicado: (2022)

The impact of comorbid impulsive/compulsive disorders in problematic Internet use
por: Chamberlain, Samuel R., et al.
Publicado: (2018)

Gambling disorder and obsessive–compulsive personality disorder: A frequent but understudied comorbidity
por: Medeiros, Gustavo C., et al.
Publicado: (2018)

Compulsive sexual behavior disorder in obsessive–compulsive disorder: Prevalence and associated comorbidity
por: Fuss, Johannes, et al.
Publicado: (2019)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

The role of the immune system in postpartum psychosis
por: Hazelgrove, Katie
Publicado: (2021)

Demographic and psychiatric correlates of compulsive sexual behaviors in gambling disorder
por: Cowie, Megan E., et al.
Publicado: (2019)

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
por: Golan, Olivia K., et al.
Publicado: (2023)

Under-representation of key demographic groups in opioid use disorder trials
por: Rudolph, Kara E., et al.
Publicado: (2022)

Peripartum and Postpartum Analgesia and Pain in Women Prescribed Buprenorphine for Opioid Use Disorder Who Deliver by Cesarean Section
por: O’Connor, Alane B, et al.
Publicado: (2022)

Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders
por: Zhang, Lusi, et al.
Publicado: (2022)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Comorbidity of Internet use disorder and attention deficit hyperactivity disorder: Two adult case–control studies
por: Bielefeld, Martin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1jkj93bg5n7pfkeda459s910ql